Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Blood
|
July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood
|
October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
The Journal of Experimental Medicine
|
November 10, 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
Maria Elena Maccari, Sebastian Fuchs, Patrick Kury, et al.
Cancer Cell
|
February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Lukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Nature Cancer
|
May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, et al.
Science Immunology
|
October 8, 2021
The expansion of human T-bet<sup>high</sup>CD21<sup>low</sup> B cells is T cell dependent
Baerbel Keller, Valentina Strohmeier, Ina Harder, et al.
Nature
|
February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine
|
February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Blood
|
July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood
|
October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
The Journal of Experimental Medicine
|
November 10, 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
Maria Elena Maccari, Sebastian Fuchs, Patrick Kury, et al.
Cancer Cell
|
February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Lukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Nature Cancer
|
May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, et al.
Science Immunology
|
October 8, 2021
The expansion of human T-bet<sup>high</sup>CD21<sup>low</sup> B cells is T cell dependent
Baerbel Keller, Valentina Strohmeier, Ina Harder, et al.
Nature
|
February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine
|
February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 12